CREM regulates the tumor immune microenvironment and predicts prognosis in thyroid carcinoma

Key Points

• Improved clinical outcomes are linked to increased expression of CREM, indicating its role as a tumor suppressor.
• Analysis shows that higher CREM expression correlates with reduced immune infiltration in thyroid carcinoma cases.
• Assessment of CREM's function suggests it may serve as a therapeutic target in immunotherapy for thyroid carcinoma.
• The findings highlight the need for further experimental validation to confirm the role of CREM in patient prognosis.